Lukas J. Geisler
Berlin, BE 10099, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Inflammatory Cytokines Associated with Diagnosis, Tumor Grade and Prognosis in Patients with Neuroendocrine Tumors.
Journal: Journal of clinical medicine
Published: July 30, 2022
Interleukin-18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis.
Journal: Hepatology (Baltimore, Md.)
Published: December 13, 2021
Low Serum Levels of Soluble Receptor Activator of Nuclear Factor κ B Ligand (sRANKL) Are Associated with Metabolic Dysregulation and Predict Long-Term Mortality in Critically Ill Patients.
Journal: Diagnostics (Basel, Switzerland)
Published: November 07, 2021
The Role of miRNA in the Pathophysiology of Neuroendocrine Tumors.
Journal: International journal of molecular sciences
Published: June 14, 2021
NOD-like receptor protein 3 activation causes spontaneous inflammation and fibrosis that mimics human NASH.
Journal: Hepatology (Baltimore, Md.)
Published: May 26, 2021
From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis.
Journal: International journal of molecular sciences
Published: January 14, 2021
Analysis of miR-29 Serum Levels in Patients with Neuroendocrine Tumors-Results from an Exploratory Study.
Journal: Journal of clinical medicine
Published: July 25, 2020
Serum levels of miR-223 but not miR-21 are decreased in patients with neuroendocrine tumors.
Journal: PloS one
Published: June 29, 2020
Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations are Elevated in Patients with Neuroendocrine Malignancies.
Journal: Journal of clinical medicine
Published: May 05, 2020
Last Updated: 09/26/2026